Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults

BACKGROUND: Neurodegenerative diseases are devastating conditions that most commonly affect individuals 65 years and older. Currently there are no effective treatments or cures for neurodegenerative diseases, and therapeutics that selectively target the underlying causes of these diseases are needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Silverman, M. H., Duggan, S., Bardelli, Geraldine, Sadler, B., Key, C., Medlock, M., Reynolds, L., Wallner, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419134/
https://www.ncbi.nlm.nih.gov/pubmed/36281667
http://dx.doi.org/10.14283/jpad.2022.71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419134/
https://www.ncbi.nlm.nih.gov/pubmed/36281667
http://dx.doi.org/10.14283/jpad.2022.71

Ejemplares similares